News – Efferon

30 November 2021

Efferon has participated in MEDICA

26 November 2021

Efferon CT treatment improves patients with severe SARS-CoV-2

09 July 2021

Efferon attracts investments from Fix Ventures

22 October 2020

Conferences in Moscow

29 April 2021

LASSO multicenter randomized trial launched

31 March 2021

Shipment to Latin America

Critical Care 2021, 25(Suppl 1): P041

Hemoperfusion with the Efferon CT extracorporeal adsorbers containing mesoporous styrene–divinylbenzene copolymer (SDC) in patients with severe COVID-19

World Journal of Medical Case Reports. Vol. 2, No. 3, 2021, pp. 46-50.

Application of novel device Efferon LPS in hemoperfusion for simultaneous removal of endotoxin and cytokines in a patient with septic shock

Therapeutic archive. 2021; 93 (7): 811-817

Extracorporeal adsorption of cytokines in cytokine release syndrome in a patient with acute lymphoblastic leukemia after therapy with T cells with a chimeric antigen receptor. Clinical observation

General resuscitation. 2020; 16 (6): 31-53.

Application of adsorbent based on a hypercrosslinked styrene-divinylbenzene copolymer with an immobilized LPS-selective ligand in hemoperfusion for the treatment of patients with septic shock

General resuscitation. 2020; 16 (4): 14-20.

Hemosorption carried out by a column filled with hypercrosslinked styrene-divinibenzene copolymer with an immobilized LPS-selective ligand in a complex of intensive treatment of acute lung injury in the surgical treatment of lung cancer (clinical observation)

General resuscitation. 2018; 14 (6): 51-60.

Efficiency and safety of a new product for LPS-selective hemosorption (experimental study)

General resuscitation. 2016; 12 (6): 82-107.

Sorbents for extracorporeal removal of toxic substances and molecules with unwanted biological activity (review)

General resuscitation. 2017; 13 (5): 109-120.

Methods for the determination of bacterial endotoxin in critical care medicine (review).

Invention patent RU 2691413 C1. Date of registration: 26.12.2017

Method for determination of bacterial endotoxin in biological fluids.

Invention patent RU 2653125 C1. Date of registration: 23.05.2017

Polymeric sorbent, method for its production and use.

Программа «Вести» о проекте «Эфферон»

Технология компании «Эфферон» оказалась эффективной для терапии осложнений коронавирусной инфекции

«Фильтры» для микробов: есть ли рынок для новых методов «очищения» крови?